INTRODUCTION
In the majority of cases, infectious diarrhoea is treated by rehydration and/or the use of antibiotics. However, the World Health Organization has stimulated the search for treatments other than antibiotics, and probiotics have been proposed as an alternative for the prevention or treatment of a number of diarrhoeal diseases (Vieira et al., 2008) . According to the currently adopted definition by the Food and Agriculture Organization/World Health Organization, probiotics are 'live micro-organisms which when administered in adequate amounts confer a health benefit to the host' (FAO/WHO, 2002) . The great advantage of therapy with probiotics is that they have few side effects such as selection of resistant bacteria and disturbance of the gastrointestinal microbial ecosystem, which can occur when antibiotics are used. Although no proof of efficacy of such treatment against intestinal infections has been demonstrated in humans, murine models have indicated that some probiotics may be efficient against bacterial infections (Jain et al., 2008 (Jain et al., , 2009 Truusalu et al., 2008; Martins et al., 2009) . Most probiotics are strains of Lactobacillus and Bifidobacterium and are used as pharmaceutical preparations or fermented dairy products. Species from other bacterial genera such as Escherichia, Bacillus and Enterococcus have also been used, but there are concerns surrounding the safety of such probiotics, as these genera contain opportunistic pathogenic species, particularly Enterococcus. Few non-bacterial micro-organisms such as yeasts (Saccharomyces boulardii) have been studied or commercialized as probiotics.
Many mechanisms of action have been proposed to explain yeast probiotic protection against bacterial infection, such as modulating the immune system (Buts et al., 1990; Rodrigues et al., 2000) , degrading Clostridium difficile toxins A and B and their respective receptors on colonic mucosa (Castagliuolo et al., 1999; Qamar et al., 2001) , inhibiting cholera toxin action (Czerucka et al., 1994; Brandão et al., 1998) and modulating the transduction pathway when activated by enteropathogenic bacteria (Czerucka et al., 2000; Dahan et al., 2003; Martins et al., 2010 Martins et al., , 2011 . Another frequently cited mechanism for probiotic action is the production of diffusible antagonistic compounds inhibiting pathogenic bacterial growth. In contrast to probiotic bacteria (particularly lactic acid bacteria), probiotic yeasts rarely show this antagonistic ability, at least in vivo (Rodrigues et al., 1996) . Finally, a study conducted by Gedek (1999) reported the adhesion of Salmonella Typhimurium, enteropathogenic Escherichia coli and enterohaemorrhagic E. coli to the probiotic yeast Saccharomyces boulardii. Pérez-Sotelo et al. (2005) also noted that the yeast Saccharomyces cerevisiae strain Sc47 binds to strains of Salmonella, particularly those that express type I fimbriae. These observations suggest that the fixation of enteropathogenic bacteria onto the surface of Saccharomyces cells could in part explain the protective effect of some yeast probiotics.
Until now, Saccharomyces boulardii has been the only yeast commercialized worldwide as a probiotic for humans, but some authors have suggested the use of other yeast species or genera based essentially on in vitro assays and a few clinical trials (Kovacs & Berk, 2000; Kumura et al., 2004; van der Aa Kühle et al., 2005) . We demonstrated previously that Saccharomyces cerevisiae strain UFMG 905 has potential as a probiotic due to its ability to protect mice against Salmonella enterica serovar Typhimurium and Clostridium difficile infection in a murine model (Martins et al., 2005) , and to inhibit bacterial translocation and modulate both local and systemic immunity of mice (Martins et al., 2007; Generoso et al., 2010) . Recent immunological data demonstrated that both Saccharomyces boulardii and Saccharomyces cerevisiae UFMG 905 decreased the levels of pro-inflammatory cytokines and modulated the activation of mitogenactivated protein kinases (p38 and JNK, but not ERK1/2), NF-kB and AP-1 signalling pathways, which are involved in the transcriptional activation of pro-inflammatory mediators induced by Salmonella infection (Martins et al., , 2011 . Preliminary results obtained from electron microscopy revealed that these probiotic effects could be due, at least in part, to the binding of Salmonella to the yeast cells.
The objective of the present study was to evaluate in vitro and in vivo the adhesion of enteropathogenic bacteria onto the surface of yeast cells as a trapping mechanism, which could explain in part the protective effect of probiotics. To understand the mechanism of adhesion of pathogens to yeast, we also used cell-wall mutants of the parental strain Saccharomyces cerevisiae BY4741.
METHODS
Micro-organisms, growth conditions and conservation. Four yeast strains (Saccharomyces boulardii 17 and Saccharomyces cerevisiae strains UFMG 905, BY4741 and W303) were used as well as 44 cell-wall mutants of Saccharomyces cerevisiae BY4741. Saccharomyces boulardii 17 and Saccharomyces cerevisiae UFMG 905 and BY4741 were selected for their ability to adhere to some pathogenic bacteria, whereas Saccharomyces cerevisiae W303 was used as a negative control for such adhesion. Saccharomyces boulardii 17 (Floratil) was provided by Merck. Saccharomyces cerevisiae UFMG 905 was from the Yeast Bank of Dr Carlos Augusto Rosa (Laborató rio de Ecologia e Biotecnologia de Leveduras, Departamento de Microbiologia, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil). The identity of the strain was first determined as Saccharomyces cerevisiae using the computer program YEASTCOMPARE (Ciriello & Lachance, 2001 ) and retrospectively confirmed by sequencing the D1/D2 variable domains of the large-subunit rRNA gene as described by Lachance et al. (1999) . Saccharomyces cerevisiae BY4741 and the 44 cell-wall deletion strains came from the European Saccharomyces cerevisiae Archive for Functional Analysis (EUROSCARF) Collection (Table 1, (FIOCRUZ), Rio de Janeiro, Brazil. The following bacteria were used as components of indigenous intestinal microbiota: E. coli Nissle 1917 (isolated from Mutaflor); Bacteroides fragilis (ATCC 25285); Bifidobacterium longum A5 (isolated from a healthy infant) and Lactobacillus delbrueckii H2B20 (isolated from a healthy newborn).
The aerobic and facultatively anaerobic pathogenic bacterial strains were cultured in brain-heart infusion broth (BHI; Difco) for 24 h at 37 uC. The anaerobic bacteria were grown for 24-48 h at 37 uC in BHI-S broth (BHI supplemented with 0.5 % yeast extract, 0.1 % menadione and 0.1 % haemin) in an anaerobic chamber (Forma Scientific) containing 85 % N 2 , 10% H 2 and 5 % CO 2 . For YLR121C Aspartic protease bound to cytoplasmic membrane through GPI preservation of each sample, 1 ml of a culture in BHI or BHI-S containing 20 % glycerol was stored in a 2 ml cryogenic tube at 280 uC.
Adhesion and sedimentation assay. The method described by Pérez-Sotelo et al. (2005) was used with some modifications to evaluate the ability of the yeast to agglutinate and deposit with the tested pathogens. Yeasts were grown in YPG medium for 24 h and then diluted with sterile saline to a concentration of 10 8 c.f.u. ml 21 . One millilitre of this yeast suspension was added to a 1.5 ml microcentrifuge tube with 500 ml (10 9 c.f.u.) of the bacteria to be tested. The resulting suspension was homogenized and incubated at room temperature for 120 min. At intervals of 0, 15, 30, 60 and 120 min, a 100 ml aliquot of supernatant was plated onto specific agar medium supplemented with 0.1 % cycloheximide to count the number of pathogenic bacteria [expressed as log (c.f.u. ml 21 )]. The control groups contained only a suspension of the bacteria to be tested.
Adhesion visualization. To visualize the ability of the yeast to agglutinate bacterial pathogens, the method described by Pérez-Sotelo et al. (2005) was used. One millilitre of yeast culture grown in YPG medium at 37 uC for 24 h under constant agitation (150 r.p.m.) and containing 10 8 c.f.u. ml 21 was mixed with 500 ml of a suspension containing 10 9 c.f.u. ml 21 of the bacteria to be tested in a six-well plate. The bacteria were grown for 24-48 h at 37 uC in BHI broth.
The presence or absence of agglutination was observed macroscopically after 15 min and 1 h, and then after a maximum time of 3 h. A sample was taken from all wells presenting agglutination, Gram stained and analysed under an optical microscope.
Evaluation of factors influencing adhesion.
pH. The adhesion and sedimentation assays described above were performed with pH values adjusted to 4.0, 5.0, 6.0 and 8.0 with 1 M HCl or 1 M NaOH.
Carbohydrates. The adhesion and sedimentation assays described above were performed in the presence of mannose, galactose, glucose or maltose, as described by Pérez-Sotelo et al. (2005) . Yeasts were diluted in 1 ml buffered saline containing 5 % (w/v) mannose, glucose, maltose or galactose to a concentration of 10 8 c.f.u. ml 21 , and an equal volume of bacterial culture containing 10 9 c.f.u. ml 21 was added. The presence or absence of adhesion was observed as described above to evaluate the influence of each carbohydrate tested.
Bile salts. To determine the occurrence of adhesion between yeasts and pathogenic bacteria in the presence of bile salts (Oxgall; Difco), cultures were treated as described by Guglielmetti et al. (2009) , with some modifications. The yeasts and bacteria were grown in YPG medium and BHI, respectively, supplemented with 1 or 3 g Oxgall l 21 for 24 h. In a second experiment, the solutions containing 1 or 3 g Oxgall l 21 were added after growth.
Yeast viability. The yeasts were killed using moist heat (121 uC for 15 min) and submitted to adhesion and sedimentation assays as described above.
Growth stage. Adhesion of pathogenic bacteria was evaluated using yeasts harvested in two phases of growth, exponential and stationary, using the assays described above for adhesion and sedimentation. All yeasts showed the same growth-curve profile in YPG medium at 37 uC, reaching the stationary phase at about 20 h. Samples representing the stationary phase were harvested after 24 h. For the exponential phase, yeast cells were harvested 1 h after resuspension of a 24 h culture in YPG medium at 37 uC.
Scanning electron microscopy (SEM). For in vitro SEM, a sample of the yeast/bacteria suspension was fixed using 2.5 % glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.2) at room temperature. After three washes with PBS, the cells were incubated on glass coverslips pre-treated with poly-L-lysine for 1 h, and two drops of 1 % osmium tetroxide plus 0.2 % potassium ferrocyanide were placed on each coverslip and the preparation left for 30 min protected from light. The coverslip was washed with PBS to remove the osmium tetroxide and dehydrated with increasing acetone concentrations (30-100 %) for 30 min for each concentration. Drying was then performed using a critical point device with CO 2 and the coverslips were glued on SEM stubs and coated with gold particles by sputtering (Pimenta & De Souza, 1986) . Finally, the samples were observed in a JEOL JSM-5600 scanning electron microscope.
Mice, and treatment and infection procedures. Germ-free 21-23day-old NIH mice (Taconic) were used in this study. The animals were housed in flexible plastic isolators (Standard Safety Equipment Company) and handled according to established procedures (Pleasants, 1974 For experiments of probiotic pathogen adhesion, germ-free mice received a single dose of 0.1 ml containing 9.0 log (c.f.u. ml 21 ) of the yeast by oral gavage, 24 h before infection. The monoxenic animals were inoculated intragastrically with 0.1 ml Salmonella Typhimurium suspension containing 7.0 log (c.f.u. ml 21 ). Control mice received only sterile water by oral gavage 24 h before the pathogenic challenge. After 2 h, the mice were sacrificed by cervical dislocation and the small intestine tissues were fixed and processed for SEM. Intestinal tissues were fixed overnight at room temperature with 2.5 % glutaraldehyde in 0.1 M cacodylate buffer (pH 6.8) containing 7 % sucrose. They were then treated with 2 % osmium tetroxide solution plus 1.6 % potassium ferrocyanide in the same buffer for 3 h. After dehydration with increasing acetone concentrations (30-100 %), the tissues were dried using a critical point device with CO 2 . The tissue samples were then mounted on SEM stubs, coated with gold particles by sputtering and analysed in a JEOL JSM 5600 scanning electron microscope.
Statistical analysis. The results were expressed as the mean of at least two independent experiments. Data were analysed using Fisher's exact test or Student's t-test at a probability level of P,0.05. Statistical analyses were performed using the program Sigma Stat version 1.0 (Jandel Scientific Software).
RESULTS

Demonstration of adhesion between yeasts and pathogenic bacteria
The adhesion of a panel of pathogenic bacteria to the surface of various yeasts was determined as aggregation by optical and electron microscopic examination and by sedimentation to determine bacterial counts in supernatants of suspensions containing the bacteria alone or associated with the yeasts. Table 2 shows that both live and heatkilled yeast cells of Saccharomyces boulardii and Saccharomyces cerevisiae UFMG 905 were able to fix Salmonella Typhimurium (from human origin, as well as ATCC 14028) and E. coli ATCC 25723 onto their surface. Flocculation between the yeasts and Salmonella Typhi or E. coli was also observed (except for live cells of Saccharomyces cerevisiae UFMG 905 and Salmonella Typhi), but the phenomenon was slower when compared with Salmonella Typhimurium. Flocculation was not observed when Saccharomyces cerevisiae W303 was used.
Counts of pathogenic bacteria in the supernatant of the adhesion/sedimentation assays confirmed the visual results. A tenfold reduction in bacterial number in the supernatant was observed when the yeasts were added, and this bacterial population reduction was statistically significant in all situations (P,0.05). The adhesion phenomenon was confirmed as being independent of yeast viability. Table 3 shows that adhesion, as determined by sedimentation assays, was not observed between the yeasts and some components of the indigenous digestive microbiota (some of which are used as probiotics), except for Saccharomyces cerevisiae UFMG 905 and Bacteroides fragilis. Fig. 1 shows a representative microscopic visualization of the various positive assays observed for adhesion. Each yeast cell was surrounded by numerous bacteria in a phenomenon similar to flocculation, which also occurred between the yeast cells themselves. Fig. 2 shows scanning electron micrographs from in vitro adhesion assays with different yeasts and pathogenic bacteria. Adhesion was clearly observed when Salmonella Typhimurium ATCC 14028 ( Fig. 2a, c) or E. coli ATCC 25723 ( Fig. 2b) was associated with Saccharomyces boulardii ( Fig. 2a) or Saccharomyces cerevisiae UFMG 905 (Fig. 2b, c) . In contrast, absence of adhesion was clearly noted when Salmonella Typhimurium ATCC 14028 was associated with Saccharomyces cerevisiae W303 (Fig. 2d ). Flocculation between yeast cells was again observed, and this phenomenon was noted more frequently for yeast strains showing adhesion with bacteria. Additionally, the bacteria, which were uniformly distributed in the observation field when there was no adhesion (Fig. 2d ), seemed to be attracted to the yeast surface in the presence of Saccharomyces boulardii or Saccharomyces cerevisiae UFMG 905 ( Fig. 2a-c ), suggesting a possible chemotaxis phenomenon.
Influence of various other factors on adhesion
To characterize some aspects of the adhesion between bacteria and yeasts, the influence of pH, the growth phase of the yeast and the presence of various carbohydrates and bile salts was evaluated. Adhesion assays were performed over a pH range of 4.0-8.0, and no influence of this factor was observed (data not shown). Table 4 shows the influence of yeast growth phase on the adhesion to pathogenic bacteria. Greater adhesion was generally observed when the yeasts were harvested in the stationary phase for the test compared with harvesting in the exponential phase, except when Salmonella Typhi was used as the pathogenic bacterium, when the opposite result was noted. The adhesion phenomenon was clearly inhibited by mannose in all situations, as shown in Table  5 . Similar inhibition was also noted for glucose and maltose but only for Saccharomyces boulardii with Salmonella Typhimurium from human origin and Salmonella Typhi. Table 6 shows that there was a marked inhibition of adhesion ability when Saccharomyces cerevisiae UFMG 905 was grown in medium containing 0.1 % bile salts before the test. The effect was not so marked when the bile salts were added after growth. However, at a higher concentration (0.3 %), bile salts inhibited the adhesion phenomenon for all associations. Table 7 shows that Saccharomyces cerevisiae B4741 presented the same adhesion capacity as Saccharomyces boulardii and Saccharomyces cerevisiae UFMG 905 when tested with the four pathogenic bacteria. Among its 44 cell-wall mutants, five had lost this adhesion capacity, YJL158C, (Table 8 ).
In vivo evaluation of adhesion using gnotobiotic mice
Demonstration and characterization of the adhesion between bacteria and yeasts as described above were determined by in vitro assays. However, it is important to demonstrate that the phenomenon can also occur in vivo.
The probable contribution of this mechanism would be difficult to demonstrate in the presence of a complex intestinal microbial ecosystem. For this reason, gnotobiotic mice were used, which provide a simplified in vivo system that allows the observation of ecological interactions in the digestive tract between a few microbial strains inoculated in this ecosystem. As can be seen in Fig. 3 , in Salmonella monoxenic mice, the bacteria covered the epithelium in an evenly distributed way (Fig. 3a) . When the mice were previously mono-associated with the yeast, binding between the yeast and bacteria was clearly observed for both Saccharomyces boulardii and Saccharomyces cerevisiae UFMG 905 (Fig. 3b, c) . As observed in Fig. 2(d) , in the presence of the probiotic Saccharomyces, the bacterial cells that were initially uniformly distributed on the intestinal epithelial surfaces seemed to be attracted to the yeast cell surface.
DISCUSSION
Adhesion to host tissue surfaces is an initial step of fundamental importance for the success of an infectious process, particularly on the gut epithelium. Adherence of microbial cells has been suggested to be the result of two essentially different mechanisms: specific and nonspecific binding. Non-specific binding involves electrostatic and hydrophobic interactions of lower affinity than for specific binding. The localization and mechanisms of binding to the epithelial surface have been studied previously in enteropathogenic bacteria such as E. coli and Salmonella, and type I fimbriae are frequently involved in this adhesion, generally using mannose as a receptor (Kline et al., 2009) . A number of different approaches have been taken over the years to inhibit adhesion of pathogenic bacteria, and addition of exogenous sugars and inhibition of fimbria assembly are two strategies that have been studied (Cusumano & Hultgren, 2009 ). The cell walls of yeasts are known to be rich in mannose, and we have hypothesized that probiotic yeasts may exert their protective effect by the trapping of pathogenic bacteria on their surface, as we observed previously in a cell-culture model for Saccharomyces boulardii . This is a reasonable hypothesis, as this could explain many of the probiotic effects observed during infection such as the inhibition of signalling transduction pathways activation and translocation (Martins et al., , 2011 .
The present study showed that Saccharomyces boulardii and Saccharomyces cerevisiae UFMG 905 aggregated a limited range of Gram-negative enteropathogenic bacteria. The observation of agglutination between yeast and Gramnegative bacteria (E. coli and Salmonella) is not a new observation and was used initially as a model to simulate and study the adhesion of pathogenic bacteria to host mammalian cells (Korhonen, 1979; Korhonen et al., 1981) . Later, a study conducted by Gedek (1999) reported the adhesion of Gram-negative enteropathogenic bacteria to Saccharomyces boulardii. The location of the binding sites of these enteric bacteria on the cell wall of Saccharomyces was studied using a lectin histochemical method and electron microscopy. The study showed that type I fimbriae of E. coli were more strongly linked to the surface of Saccharomyces boulardii than to other strains of Saccharomyces cerevisiae. Pérez-Sotelo et al. (2005) also noted that the yeast Saccharomyces cerevisiae Sc47 bound to strains of Salmonella, particularly those expressing type I fimbriae. In this case, the affinity was mediated by cell-wall mannose residues, and the binding capacity was influenced by the growth conditions of the Salmonella, such as temperature and pH.
Interestingly, although Saccharomyces boulardii has been demonstrated to be able to fix cholera toxin onto its surface (Brandão et al., 1998) , its adhesion to V. cholerae toxin-producing cells was not observed here. Previous Bacterial trapping on probiotic yeast surface reports have shown that Salmonella strains that express type I fimbriae have some affinity to Saccharomyces boulardii. This affinity is mediated by mannan oligosaccharides of the yeast cell wall and can be inhibited by mannose complexes (Gedek, 1999) . The aggregation between yeast and bacteria described in our study was also inhibited by mannose. In previous studies, transmission electron micrographs showed that the bacterial pili are in contact with yeast. Once the yeast fixed the bacteria on its surface, a diminished or inhibited signalling cascade was generated by a lower number of bacteria in direct contact with the host cell (Martins et al., , 2011 . (2002) , who showed that growth of two Bifidobacterium bifidum strains in bile altered their adhesion to Caco-2 cells more markedly than when the same bacteria were shocked with bile after having been grown in a bile-free medium. The same authors correlated the changes in adhesion with a decrease in surface hydrophobicity and an increase in surface potential. Moreover, they proposed that changes in surface and adhesion properties may correlate with changes in sugar components induced by bile during growth (Gó mez-Zavaglia et al., 2002) . With regard to the influence of bile salts on the adhesion ability of yeast, no report has been found in the literature.
In relation to the influence of growth phase on the adhesion phenomenon, it is well known that yeasts frequently flocculate in the stationary phase, and this characteristic has a high practical importance in the brewing industry (Stratford, 1993) . Flocculation of yeast cells involves lectin-like proteins -so-called flocculins -that stick out of the cell walls of flocculent cells and selectively bind mannose residues present in the cell walls of adjacent yeast cells. Flocculation is inhibited by mannose in the growth medium, presumably because free mannose occupies the flocculin-binding sites so that they can no longer bind the mannose residues of other cells. However, the results of the present study did not allow us to determine whether, in addition to mannose, flocculin might also be involved.
Another interesting aspect of the present results was that yeast viability was not necessary for the adhesion phenomenon. This property could open the possibility of using nonviable yeast cells in immunocompromised patients, in which treatment with live probiotics is not recommended due to the possible occurrence of opportunistic infection (although rarely observed) (Boyle et al., 2006) .
Although the adhesion phenomenon has been clearly demonstrated and visualized in vitro in the present study as well as in previous preliminary reports (Gedek, 1999; Pérez-Sotelo et al., 2005; Martins et al., 2010 Martins et al., , 2011 , it is not known whether it occurs in vivo. For this purpose, an animal model using germ-free mice was used to confirm and visualize the interaction between the yeast and the pathogenic bacterium on the intestinal epithelium. The gnotobiotic animal provides a simplified model that allows the observation of interrelationships between a few microbial strains inoculated into the gastrointestinal ecosystem without the interference of the complex indigenous microbiota. The data obtained here clearly showed adhesion between the enteropathogenic bacteria and the yeast on the intestinal epithelium. The results of both in vitro and in vivo visualization of adhesion also suggested that a chemotaxis phenomenon could be involved in these interactions between the bacteria and yeasts.
The use of cell-wall deletion mutants of Saccharomyces cerevisiae BY4741 showed that five of the 44 mutants tested lost their ability to adhere to pathogenic bacteria. The mutant strains were YJL158C, YKL096W-A, YMR306W, YKL163W and YGR279C. Mutation of YJL158C (gen CIS3) is related to a cell-wall mannose-containing glycoprotein, which is a member of the PIR family. YKL096W-A (CWP2) has a mutation of a covalently linked cell-wall mannoprotein, a major constituent of the cell wall, which plays a role in cell-wall stabilization and acid resistance. For YMR306W (gen FKS3), the mutation involves a protein acting in spore wall assembly, which has similarity to the 1,3-b-D-glucan synthase catalytic subunits FKS1p and Gsc2p. Mutation of YKL163W (gen PIR3) is related to a glycosylated covalently bound cell-wall protein required for cell-wall stability. Its expression is cell-cycle regulated, peaking in M/G 1 , and is also subjected to regulation by the cell-wall integrity pathway. Finally, for YGR279C (gen SCW4), the mutation involves a cell-wall Table 8 . Adhesion of enteropathogenic bacteria to the five cell-wall mutants of Saccharomyces cerevisiae BY4741, determined by bacterial count [log (c.f.u. ml "1 )] in the supernatant after sedimentation
None of the bacterial counts in the supernatants of the yeast-bacteria associations were significantly different from those of the counterpart control without yeast (Student's t-test, P.0.05).
protein with similarity to glucanases. As described above, only the first two strains had a more direct participation of mannose in their mutations, which could explain their effect on adhesion. However, various other mutant strains involving mannose did not lose their adhesion ability. For the last three strains, the influence of the mutation on the loss of bacterial adhesion is less clear.
In conclusion, the present study showed that some enteropathogenic bacteria were captured on the surface of Saccharomyces boulardii, Saccharomyces cerevisiae UFMG 905 and Saccharomyces cerevisiae BY4741, and this could be one mechanism by which probiotic yeasts prevent pathogen adhesion to specific receptors on the intestinal epithelium and subsequent invasion of the host. However, this trapping mechanism was limited to some specific Gram-negative enteropathogens (Salmonella and E. coli), and the search for a yeast probiotic presenting a wider range of adhesion ability could be of interest. Another approach to improve the use of this possible probiotic property involves a better genetic and mechanistic understanding of the adhesion phenomenon, which could lead to its superexpression. 
